Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 9, Issue 11, Pages e002917
Publisher
BMJ
Online
2021-11-02
DOI
10.1136/jitc-2021-002917
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
- (2021) Thomas Powles et al. NEW ENGLAND JOURNAL OF MEDICINE
- TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors
- (2021) Scott T. Tagawa et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical development of therapies targeting TGFβ: current knowledge and future perspectives.
- (2020) D. Ciardiello et al. ANNALS OF ONCOLOGY
- Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer
- (2020) Ginette S. Santiago-Sánchez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
- (2020) Reem Saleh et al. CANCER LETTERS
- S100A8 and S100A9 promote endothelial cell activation through the RAGE‑mediated mammalian target of rapamycin complex 2 pathway
- (2020) Xiang Zhong et al. Molecular Medicine Reports
- Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
- (2020) Thomas Powles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
- (2019) Yohann Loriot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enrichment of genes associated with squamous differentiation in cancer initiating cells isolated from urothelial cells transformed by the environmental toxicant arsenite
- (2019) Zachary E. Hoggarth et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- NOX1-Dependent mTORC1 Activation via S100A9 Oxidation in Cancer Stem-like Cells Leads to Colon Cancer Progression
- (2019) Hirokazu Ohata et al. Cell Reports
- Long‐term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2‐year follow‐up of the CHRONOS‐1 study
- (2019) Martin Dreyling et al. AMERICAN JOURNAL OF HEMATOLOGY
- Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer
- (2019) Yoshie Kobayashi et al. SEMINARS IN CANCER BIOLOGY
- Molecular Subtype-Specific Immunocompetent Models of High-Grade Urothelial Carcinoma Reveal Differential Neoantigen Expression and Response to Immunotherapy
- (2018) Ryoichi Saito et al. CANCER RESEARCH
- Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation
- (2018) Thomas Vogl et al. JOURNAL OF CLINICAL INVESTIGATION
- Bevacizumab Reduces S100A9-Positive MDSCs Linked to Intracranial Control in Patients with EG FR -Mutant Lung Adenocarcinoma
- (2018) Po-Hao Feng et al. Journal of Thoracic Oncology
- PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux
- (2018) Jake S. O’Donnell et al. SEMINARS IN CANCER BIOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
- (2018) A. Gordon Robertson et al. CELL
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Vibrio vulnificus RtxA Is a Major Factor Driving Inflammatory T Helper Type 17 Cell Responses in vitro and in vivo
- (2018) Arim Lee et al. Frontiers in Immunology
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Lipocalin 2: a potential therapeutic target for breast cancer metastasis
- (2018) Chenxia Hu et al. OncoTargets and Therapy
- The Isoform Selective Roles of PI3Ks in Dendritic Cell Biology and Function
- (2018) Ezra Aksoy et al. Frontiers in Immunology
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- (2017) Joaquim Bellmunt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long non-coding RNA MALAT-1 modulates metastatic potential of tongue squamous cell carcinomas partially through the regulation of small proline rich proteins
- (2016) Zhengyu Fang et al. BMC CANCER
- PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment
- (2016) Angel Guerrero-Zotano et al. CANCER AND METASTASIS REVIEWS
- Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
- (2016) Olivier De Henau et al. NATURE
- Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
- (2015) W. Peng et al. Cancer Discovery
- Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
- (2015) Rikke B. Holmgaard et al. Cell Reports
- Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy
- (2015) Chong-xian Pan et al. PLoS One
- Study of small proline-rich proteins (SPRRs) in health and disease: a review of the literature
- (2013) Fernanda Carregaro et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway
- (2013) Yun-Peng Wang et al. HEPATOLOGY
- BAY 80-6946 Is a Highly Selective Intravenous PI3K Inhibitor with Potent p110α and p110δ Activities in Tumor Cell Lines and Xenograft Models
- (2013) Ningshu Liu et al. MOLECULAR CANCER THERAPEUTICS
- Expression of SPRR3 is associated with tumor cell proliferation in less advanced stages of breast cancer
- (2011) Jin Cheon Kim et al. BREAST CANCER RESEARCH AND TREATMENT
- Lipocalin 2: A multifaceted modulator of human cancer
- (2011) Jiang Yang et al. CELL CYCLE
- Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers
- (2011) T. Reinert et al. CLINICAL CANCER RESEARCH
- PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer
- (2008) C A Crane et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started